Research Article
Improving Diabetes Care: A Fijian Diabetes Service Improvement Study
Table 3
Description of comorbidities present in the study population. Type 2 diabetes related comorbidities in the study population (
).
| | Comorbidities | |
| | Macrovascular diseases | 36% (42) | | IHD | 36% (41) | | Stroke | 4% (5) | | PVD | 1% (1) | | Concurrent macrovascular diseases | | | IHD + stroke | 4% (4) | | IHD + PVD | 1% (1) |
| | Microvascular diseases | 33% (37) | | CKD | 27% (31) | | Retinopathy | 1% (1) | | Peripheral neuropathy | 3% (3) | | Amputation | 3% (3) | | Concurrent microvascular diseases | | | Retinopathy + peripheral neuropathy | 1% (1) |
| | Metabolic syndrome (hypertension + dyslipidemia) | 5% (6) | | Hypertension only | 27% (30) | | Hypertension + other disease states | 77% (87) |
| | No co-morbidities | 4% (5) |
|
|
Key: IHD: ischemic heart disease; PVD: peripheral vascular disease; CKD: chronic kidney disease.
|
